Abstract
The goal of primary cytoreductive surgery for the treatment of advanced ovarian cancer (FIGO stages II–IV) should be to achieve a reduction to microscopic disease, as cytoreduction to nodules of less than 1 cm in maximum diameter is associated with a clear benefit in terms of overall survival compared with patients who have larger residual disease. 1 Shih KK Chi DS Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol. 2010; 21: 75-80 Crossref PubMed Scopus (100) Google Scholar
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
